Canine leishmaniasis

Canine leishmaniasis is a zoonotic disease caused by the Leishmania parasite, which is transmitted by the bite of infected sandflies. This disease primarily affects dogs, but it can also infect other animals and humans. Canine leishmaniasis is prevalent in regions such as the Mediterranean Basin, South America, and parts of Asia and Africa.
Etiology[edit]
The causative agent of canine leishmaniasis is the Leishmania infantum species. The parasite is transmitted through the bite of infected Phlebotomine sandflies. Once inside the host, the parasite infects macrophages and other cells of the immune system.
Clinical Signs[edit]
The clinical signs of canine leishmaniasis can vary widely, ranging from asymptomatic infections to severe, life-threatening disease. Common symptoms include:
Diagnosis[edit]
Diagnosis of canine leishmaniasis involves a combination of clinical signs, serological tests, and molecular techniques. Common diagnostic methods include:
- Serology (e.g., ELISA, IFAT)
- Polymerase chain reaction (PCR)
- Biopsy and histopathology
Treatment[edit]
Treatment of canine leishmaniasis typically involves the use of antileishmanial drugs such as meglumine antimoniate, miltefosine, and allopurinol. However, treatment can be challenging due to the chronic nature of the disease and the potential for relapse.
Prevention[edit]
Preventive measures include:
- Use of insect repellents and insecticide-treated collars
- Keeping dogs indoors during peak sandfly activity times
- Vaccination (where available)
Prognosis[edit]
The prognosis for dogs with leishmaniasis varies depending on the severity of the disease and the response to treatment. Early diagnosis and appropriate management can improve the outcome.
Public Health Implications[edit]
Canine leishmaniasis is a significant public health concern due to its zoonotic potential. Infected dogs can serve as reservoirs for human infection, making control measures essential to reduce the risk of transmission to humans.
Related Pages[edit]
Categories[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian